For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Enzon, Inc.

USPTO Granted Patents = 100

CIPO Patents = 1

Trademarks = 1

Forward Citations = 7,831

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Richard B Greenwald (49 out of 61 patents)

Annapurna Pendri (21 out of 45 patents)

David R Filpula (21 out of 28 patents)

4. Marc D Whitlow (19 out of 20 patents)

5. Anthony J Martinez (16 out of 23 patents)

6. Robert G Shorr (15 out of 34 patents)

7. Yun Hwang Choe (12 out of 16 patents)

8. Hong Zhao (10 out of 36 patents)

9. Maoliang Wang (8 out of 10 patents)

10. Robert E Bird (7 out of 14 patents)

11. Karl D Hardman (7 out of 12 patents)

12. Kwang Nho (7 out of 7 patents)

13. Carl W Gilbert (7 out of 13 patents)

14. Lihsyng Standford Lee (6 out of 6 patents)

15. Shmuel Zalipsky (6 out of 6 patents)

Core Competencies:

Polyalkylene Oxide

Polymeric Prodrugs

Single-Chain Polypeptides

Biodegradable Linkers

Antigen-Binding Proteins

Nucleic Acid Delivery

Polymer Conjugates

Amino Acid Derivatives

High Molecular Weight Polymers

Camptothecin Derivatives

Interferon Conjugates

Trialkyl-Lock Prodrugs

100 patents: Sort by Forward Citations

1. 7632504 - Polyalkylene oxide-modified single chain polypeptides (2009-12-15),

2. 7393953 - Polymeric acyl derivatives of indoles (2008-07-01),

3. 7262164 - Polymeric thiol-linked prodrugs employing benzyl elimination systems (2007-08-28),

4. 7150872 - Polyalkylene oxide-modified single chain polypeptides (2006-12-19),

5. 7122189 - Releasable polymeric conjugates based on aliphatic biodegradable linkers (2006-10-17),

6. 6936597 - Prodrugs of anticancer agents employing substituted aromatic acids (2005-08-30),

7. 6872393 - Polyalkylene oxide-modified single chain polypeptides (2005-03-29),

8. 6824782 - Polyalkylene oxide-modified single chain polypeptides (2004-11-30),

9. 6824766 - Biodegradable high molecular weight polymeric linkers and their conjugates (2004-11-30),

10. 6756037 - Polymer conjugates of biologically active agents and extension moieties for facilitating conjugation of biologically active agents to polymeric terminal groups (2004-06-29),

11. 6743908 - Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof (2004-06-01),

12. 6743896 - Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof (2004-06-01),

13. 6692942 - Single-chain polypeptides for targeted delivery of nucleic acids (2004-02-17),

14. 6649778 - Methods of preparing amino acid taxane derivatives and polymer conjugates containing the same (2003-11-18),

15. 6638499 - Terminally-branched polymeric linkers and polymeric conjugates containing the same (2003-10-28),

Enzon, Inc. is a pharmaceutical company specializing in the development and commercialization of innovative therapeutics. With a focus on biopharmaceutical products, Enzon strives to address unmet medical needs in areas such as oncology and hematology. By leveraging its expertise in protein engineering and drug delivery systems, the company aims to provide effective treatment options to patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

100 Patents

#7 in Bridgewater, NJ

#173 in New Jersey

#3,652 in US

#7,559 in the World

Bridgewater, NJ, United States of America

Enzon, Inc.

Forward Citations = 7,831

54 inventors:

Richard B Greenwald (49 out of 61 patents)

Annapurna Pendri (21 out of 45 patents)

David R Filpula (21 out of 28 patents)

4. Marc D Whitlow (19 out of 20 patents)

5. Anthony J Martinez (16 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…